Patients Achieved Remission Within 30 Days in Cohort 1 of the Mipletamig RAINIER Dose Optimization Trial for Frontline AML Patients, Trial Enrollment Continues Promising Data, including a 59% Stable ...
Dr Farzan Malekzadeh, owner of FMX beauty based in Turkey, who goes by @Dr.FrzmkZ on social media, says his transformations ...